As a leadership team, we are focused on high performance to benefit patients, clinicians, and shareholders.
MICHAEL F. MAHONEY
President and Chief Executive Officer
Senior Vice President and President Interventional Cardiology
DANIEL J. BRENNAN
Executive Vice President and Chief Financial Officer
Senior Vice President, General Counsel and Corporate Secretary
Senior Vice President Human Resources
Senior Vice President and President, Endoscopy
JOSEPH M. FITZGERALD
Executive Vice President and President, Rhythm Management
Executive Vice President, Operations
Senior Vice President and President, Peripheral Interventions
Senior Vice President and President, Neuromodulation
Executive Vice President and Global Chief Medical Officer
DAVID A. PIERCE
Executive Vice President and President, MedSurg
Senior Vice President, Manufacturing and Supply Chain
Senior Vice President and President, Europe
Senior Vice President and President, Asia Pacific
Michael Mahoney is President and Chief Executive Officer of Boston Scientific Corporation and a member of the company’s board of directors. Mahoney oversees global development, marketing and sales of the company’s broad medical solutions portfolio. He assumed this role in November 2012, after serving one year as president of Boston Scientific, leading the Cardiac Rhythm Management (CRM) and Endoscopy (GI and Pulmonary) business divisions. Mahoney joined the company in October 2011, with a 24-year track record of building market-leading medical device, capital equipment and healthcare IT businesses.
Prior to Boston Scientific, Mahoney served as Worldwide Chairman of Johnson & Johnson’s Medical Devices and Diagnostics (MD&D) division, overseeing seven franchises and 50,000 employees. He previously served as Worldwide Group Chairman of Johnson & Johnson’s DePuy orthopedics and neuro-sciences business, where he drove growth through product innovation, acquisitions and market expansion into China and India.
Mahoney was President and Chief Executive Officer of Global Healthcare Exchange (GHX), a leading supply chain solutions company. He built GHX through organic development, seven strategic acquisitions and expanding into Canada and Europe. For the first 12 years of Mahoney’s career, he advanced through a series of leadership roles at General Electric Medical Systems, reaching the position of General Manager of the company’s Healthcare Information Technology business.
Mahoney serves on AdvaMed's board of directors and is a member of the American Heart Association CEO Roundtable. He earned a B.B.A. in Finance from the University of Iowa and his M.B.A. from Wake Forest University. Mike is married and has three children.
Kevin Ballinger is Senior Vice President and Global President, Interventional Cardiology for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for developing and bringing to market innovative solutions that diagnose and treat coronary artery disease and cardiac valve disorders.
Ballinger has more than 17 years of interventional cardiology experience. Prior to his current role, he held a variety of engineering and general management positions within Boston Scientific’s Interventional Cardiology business unit, including overseeing the development of the company’s first drug-eluting stents.
Ballinger earned a B.S. in Mechanical Engineering from Michigan Tech University and an MBA from the University of Minnesota.
Daniel Brennan is Executive Vice President and Chief Financial Officer for Boston Scientific Corporation and a member of its Executive Committee. In this role, he is responsible for several Company functions, including Global Controllership, Corporate Finance, Treasury, Corporate Tax, Corporate Analysis and Control, and Corporate New Business Development.
Previously, he served as Senior Vice President and Corporate Controller. In this role, Brennan was responsible for the Global Controllership organization, including the Company’s accounting and financial planning processes.
Brennan joined Boston Scientific in 1996 and has served in a number of financial roles of increasing responsibility, including Assistant Corporate Controller; Vice President-Worldwide Financial & Strategic Planning; Vice President-Investor Relations, Vice President-International Finance and Vice President-Finance & Information Technology for the company’s Cardiovascular Division.
Prior to joining Boston Scientific, Brennan held several finance positions at Millipore Corporation and Standex Corporation.
Brennan is a Certified Public Accountant and earned his B.S. in Finance and Investments and his M.B.A. from Babson College.
Wendy Carruthers is Senior Vice President of Human Resources for Boston Scientific Corporation and a member of its Executive Committee. In this role, she provides strategic leadership to the global HR function, including HR operations, total rewards, talent management, diversity and inclusion, and community relations.
Prior to her current role, Carruthers served as Vice President of Global Talent Management for Boston Scientific, responsible for all aspects of global talent management including the design, development and implementation of global processes and systems to enable managers to identify, attract and develop people.
Carruthers has been with Boston Scientific since 2004 and was previously Vice President of Human Resources for the company’s Europe, Middle East and Africa (EMEA) region, based in Paris.
Prior to joining Boston Scientific, Carruthers was Vice President of Human Resources, Europe for global telecommunications company Cable & Wireless. She also previously worked in human resources for Diageo, a premium drinks business, and Tesco, a U.K. retailer.
A native of Great Britain, Carruthers has lived and worked in the U.K., France, Italy, Australia and the United States. She holds a B.A. First Class Honors Degree in Modern Languages and is a Fellow of the Chartered Institute of Personnel and Development. She is also on the Board of the Boston Scientific Foundation and a member of the Board of Advisors of the Greater Boston Food Bank.
Arthur Butcher is Senior Vice President and President, Endoscopy Division for Boston Scientific. In this role, he is responsible for developing and bringing to market less invasive devices for treating gastrointestinal and pulmonary conditions.
Prior to his current role, Butcher was Vice President & General Manager, Japan Endoscopy Business. Since joining the Company in 1997, he has held a variety of marketing and strategic planning management positions within the Endoscopy and Urology and Pelvic Health divisions.
Butcher holds a B.A. in International Relations from the University of Pennsylvania and an M.B.A. from Columbia University.
Joe Fitzgerald is Executive Vice President and President, Rhythm Management for Boston Scientific and a member of its Executive Committee.
Prior to his current role, Fitzgerald was President of Boston Scientific's Endovascular Unit, which included the Company's Peripheral Interventions, Electrophysiology, Neurovascular and IVUS businesses. Previously, he held a number of senior leadership positions at Boston Scientific, including President of our Electrophysiology business and Vice President of Global Marketing and U.S. Sales for the Company's Neurovascular business.
Edward Mackey is Executive Vice President, Operations for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for Global Manufacturing and Supply Chain, Quality and Regulatory, Information Services, Global Business Services, Global Business Excellence, Corporate Research and Development and Corporate Strategy and Marketing.
Ed is a seasoned executive with a track record of delivering strong results, leading large teams and developing innovative strategies. Prior to joining Boston Scientific in 2015, Ed was Worldwide President of DePuy Synthes Power Tools, a division of Johnson & Johnson, after having served as Vice President of Integration for Johnson & Johnson’s acquisition of Synthes.
Early in his career, Ed held management positions in Operations, Quality and Product Development at Raytheon’s Missile Systems division. In 1995, he moved to Johnson & Johnson Orthopaedics as a plant manager and progressed through a series of manufacturing and supply chain leadership roles, becoming Worldwide Vice President of Supply Chain and Manufacturing for DePuy in 2007.
Mr. Mackey holds a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute and an MBA from the University of Massachusetts.
Jeff Mirviss is Senior Vice President and President, Peripheral Interventions for Boston Scientific and a member of its Executive Committee. In that capacity he is responsible for developing and bringing to market innovative solutions for treating patients with high blood pressure, vascular system blockages and cancer.
Mirviss has more than 23 years of experience in medical device and pharmaceutical general management, marketing and sales. He has held positions of increasing responsibility since 1997 at Boston Scientific.
In addition to his roles at Boston Scientific, Mirviss has worked for companies ranging in size from a pre-revenue venture-backed medical device startup to Dow 30 companies.
A resident of Plymouth, Minn., Mirviss holds a Bachelor’s degree from the University of Minnesota and an MBA from the University of St. Thomas.
Maulik Nanavaty is Senior Vice President and President, Neuromodulation Division for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for the innovation leader in less-invasive microelectronic implantable technologies used to treat chronic neuropathic pain.
Prior to his current role, Nanavaty was President, Representative Director of Boston Scientific Japan. Previously, he was Vice President and General Manager of the Company's Interventional Cardiology business in Japan. During his tenure, Nanavaty managed the successful expansion of Cardiology business in that country. He joined Boston Scientific in 2005 as Vice President for Corporate Strategy for Japan, where he led business transformation and increased operational efficiency.
Prior to joining Boston Scientific, Nanavaty spent 16 years working in various executive positions at Baxter International, Inc., and Baxter Japan.
Nanavaty earned a Ph.D. in Pharmaceutical Sciences from the University of Illinois and a M.B.A. from the University of Chicago.
Nanavaty is a member of the Board of Directors for the California Health Institute (CHI). CHI is an independent 501(c)(6) organization devoted to researching and advocating policy to forward the interests of California's biomedical community.
Professor Ian Meredith is Executive Vice President and Global Chief Medical Officer for Boston Scientific and a member of the Executive Committee. In this role, he is responsible for leading clinical and medical affairs across Boston Scientific and providing global leadership of the company’s clinical trial strategy.
Prior to joining Boston Scientific in 2017, Professor Meredith served as Professor and Director of MonashHeart, the Cardiology service within Monash Health in Melbourne, Australia and one of the largest cardiac care services in Australia. He was also Professor of Medicine and Cardiology at Monash University in Melbourne and Executive Director of the Monash Cardiovascular Research Centre at Monash University.
With more than 25 years of experience as a clinical and interventional cardiologist, Professor Meredith has performed more than 12,000 cardiac and coronary procedures, published more than 350 peer-reviewed manuscripts and book chapters and championed many new treatment paradigms into daily clinical practice. He has been the chief or principal investigator on more than 50 major international multi-center trials and was the global principal investigator for the Boston Scientific Lotus™ Valve REPRISE research program.
Professor Meredith has served on numerous national and international professional boards, government committees and advisory boards including the Australian Department of Health and Human Services, Cardiac Services Review and the Federal Government Department of Health & Aging Cardiac Prostheses Advisory Group. He received an Order of Australia (AM) for outstanding service to medicine in the field of Cardiology as a clinician and researcher and through advisory roles with a range of public health organizations.
Professor Meredith completed his undergraduate medical education in Melbourne and his PhD at the Baker Institute before embarking on post-graduate training at the Brigham and Women’s Hospital and Harvard Medical School in Boston.
David A. Pierce is our executive vice president and president of MedSurg, a position he has held since April 2018. In this role, he will have direct responsibility for Urology and Pelvic Health, Endoscopy business, Canada and the Latin America region, and Corporate Marketing and Market Access. Prior to his current role, Mr. Pierce served as senior vice president and president, Urology and Pelvic Health, since July 2016; senior vice president and president, Endoscopy since 2011, and vice president, Marketing for Endoscopy as well as group marketing director in the Endoscopy business. He joined Boston Scientific in 1991 as a territory manager before assuming management-level positions of increasing responsibility. Prior to joining Boston Scientific, Mr. Pierce also served as senior sales representative for Airborne Express and as a Captain in the United States Army. He earned a B.S. in Business Administration from Norwich University and an M.B.A. from Boston University.
Brad Sorenson is Senior Vice President, Manufacturing and Supply Chain for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for the global manufacturing and distribution of Boston Scientific’s products.
Sorenson has more than 16 years of medical device manufacturing experience. Prior to his current role, he held a variety of Operations positions at Boston Scientific, supporting the Cardiac Rhythm Management, Neuromodulation, Interventional Cardiology, Peripheral Interventions and Structural Heart businesses. Before joining Boston Scientific, he was President and COO of QRS Diagnostic and held manufacturing management positions at Federal Cartridge.
Sorenson earned a B.A. in Economics from Gustavus Adolphus College in St. Peter, MN and an MBA from the University of Minnesota.
Eric Thépaut is Senior Vice President and President, Europe for Boston Scientific and a member of its Executive Committee. Based at the regional headquarters in Paris, he is responsible for Boston Scientific’s businesses in Europe.
Prior to his current role, Thépaut was Vice President Interventional Cardiology & Structural Heart, Europe, since 2012. He joined Boston Scientific Europe, in 1996, as a business finance manager and earned roles of increasing responsibility in Marketing and Finance, becoming Vice President, Finance, Europe, in 2002. Eric was next promoted to General Manager and Vice President, France, and then the France Group, comprised of France, Benelux and Middle East North Africa. Before coming to Boston Scientific, Eric held management positions in treasury operations and auditing at Nestlé and financial planning & analysis at Apple Computer.
Thépaut has driven innovation in high technology businesses throughout his career, leading organizational transformation initiatives and development programs as well as creating new selling models.
Eric earned his MBA at Paris Dauphine University.
Warren Wang is our senior vice president and president, Asia Pacific, a position he has held since January 2018. In this role, he is responsible for the overseeing the continued growth of our company in Asia Pacific and the ongoing development of our leadership teams. Prior to his current role, he was president and managing director, North Asia from January 2016 to December 2017. Mr. Wang joined Boston Scientific in 2012 as vice president and managing director for China. Mr. Wang is known for successfully championing strategic collaborations with local organizations to increase our presence and local innovation development in China, such as our work with Frankenman Medical Equipment, PINS Medical Equipment Company, Tsinghua University and the International Health Industry Innovation Fund. Mr. Wang earned his Bachelor in Economics from the University of International Business and Economics, Beijing and a M.B.A. in Marketing and Finance from the University of Chicago, Booth School of Business.